M/s. Uspl Nutritionals Llc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: M/s. Uspl Nutritionals Llc Pharmaceutical Import Records from India — 2 Products, $399.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M/s. Uspl Nutritionals Llc — Pharmaceutical Importer Profile (2026) | 2 Products, $399.8K Trade | TransData Nexus

M/s. Uspl Nutritionals Llc

Pharmaceutical Importer · United States · Nutritional Supplements Focus · $399.8K Total Trade · DGFT Verified

M/s. Uspl Nutritionals Llc is a pharmaceutical importer based in United States with a total trade value of $399.8K across 2 products in 1 therapeutic categories. Based on 10 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. M/s. Uspl Nutritionals Llc sources from 2 verified Indian suppliers, with Amol Pharmaceuticals Private Limited accounting for 74.8% of imports.

M/s. Uspl Nutritionals Llc — Import Portfolio & Supplier Network

M/s. Uspl Nutritionals Llc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M/s. Uspl Nutritionals Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Amol Pharmaceuticals Private Limited	$702.1K	17	74.8%
Unique Biotech Limited	$236.9K	7	25.2%

M/s. Uspl Nutritionals Llc sources from 2 verified Indian suppliers across 9 distinct formulations.

What Formulations Does M/s. Uspl Nutritionals Llc Import?

Formulation	Value	Ships
Amino trit	$300.0K	6
L-theanine	$255.8K	7
Melatonin regular	$100.0K	2
Probiotics-bacillus coagulans unique-is215 billion cfu/GM	$89.7K	3
Probiotics-bacillus coagulans	$82.4K	2
Probiotics-bacillus coagulans (unique-is2) 15 billion	$32.4K	1
Probiotics-bacillus coagulans (unique-is2) 15 billion cfu/GM	$32.4K	1
Melatonin strong	$32.1K	1
Pharmaceutical items/medicaments	$14.1K	1

M/s. Uspl Nutritionals Llc imports 9 distinct pharmaceutical formulations. Showing top 9 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Probiotics	Nutritional Supplements	$249.8K	7	2.5%	10
2	Melatonin	Nutritional Supplements	$150.0K	3	1.6%	6

M/s. Uspl Nutritionals Llc imports 2 pharmaceutical products across 1 categories into United States totaling $399.8K.

M/s. Uspl Nutritionals Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M/s. Uspl Nutritionals LLC, also known as US Pharma Lab, is a pharmaceutical importer and wholesaler headquartered at 1300 Airport Road, North Brunswick, New Jersey, United States. Established in 2009, the company specializes in the importation and distribution of dietary supplements and finished pharmaceutical formulations. With an estimated annual revenue of $50.2 million and a workforce of approximately 25 employees, USPL Nutritionals plays a significant role in the U.S. pharmaceutical supply chain.

The company's product portfolio primarily focuses on nutritional supplements, including probiotics and melatonin, sourced from international suppliers, notably India. USPL Nutritionals is recognized for its commitment to quality and innovation, partnering with leading raw material manufacturers worldwide to ensure the highest standards in its offerings.

2Distribution Network

USPL Nutritionals operates from its North Brunswick, New Jersey facility, which serves as the central hub for its distribution activities. The company imports finished pharmaceutical formulations from various international suppliers, with a significant portion sourced from India. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic location in New Jersey provides advantageous access to major U.S. markets and ports, facilitating efficient distribution across the United States.

3Industry Role

In the U.S. pharmaceutical supply chain, USPL Nutritionals functions as a pharmaceutical importer and wholesaler. The company imports finished pharmaceutical formulations, such as probiotics and melatonin, from international suppliers, particularly from India. By sourcing these products, USPL Nutritionals contributes to the diversification and availability of pharmaceutical products in the U.S. market, catering to the growing demand for dietary supplements and nutraceuticals.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M/s. Uspl Nutritionals Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

USPL Nutritionals demonstrates a high degree of sourcing concentration, with a total import value of $400K USD from India across 10 shipments, focusing on two primary products: probiotics and melatonin. This concentration indicates a strategic choice to leverage specialized suppliers for these specific formulations. The relationship stability is evidenced by the consistent import volumes and the reliance on two main suppliers: Amol Pharmaceuticals Private Limited and Unique Biotech Limited. However, this dependency also presents a potential risk, as any disruptions with these suppliers could significantly impact USPL Nutritionals' product availability.

2Supply Chain Resilience

The resilience of USPL Nutritionals' Indian supply chain is influenced by its reliance on two primary suppliers for its finished pharmaceutical formulations. While this focused sourcing strategy allows for streamlined operations, it also exposes the company to risks associated with supplier disruptions. The company's limited supplier base may affect its ability to adapt to changes in supply conditions or to diversify its product offerings. Additionally, the exposure to specific shipping routes and potential regulatory changes in India could impact the consistency and reliability of the supply chain.

Strategic Implications

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces regulations to ensure that imported drugs meet U.S. standards for safety, efficacy, and quality. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which outlines the requirements for drug approval, labeling, and manufacturing practices. For Indian generics to be marketed in the U.S., they must undergo the FDA's Abbreviated New Drug Application (ANDA) process, demonstrating bioequivalence to the reference listed drug.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in the U.S. are stringent. Importers must ensure that their products are manufactured in facilities compliant with Good Manufacturing Practices (GMP) as recognized by the FDA. While certifications such as EU GMP, WHO GMP, and PIC/S are respected, the FDA requires that foreign manufacturing facilities be inspected and approved by the agency or have a valid GMP certificate from a recognized authority. Additionally, importers must obtain an FDA registration and listing for their products, ensuring that all imported drugs are properly documented and authorized for sale in the U.S. market.

M/s. Uspl Nutritionals Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

USPL Nutritionals' focus on importing probiotics and melatonin aligns with the growing consumer demand for dietary supplements that support digestive health and sleep quality. The company's strategic choice to import these specific therapeutic areas reflects an understanding of market trends and consumer preferences. By sourcing these products from India, USPL Nutritionals leverages cost-effective manufacturing while ensuring access to high-quality formulations, thereby meeting the needs of health-conscious consumers in the U.S. market.

2Sourcing Profile

USPL Nutritionals employs a sourcing strategy that emphasizes importing finished pharmaceutical formulations, particularly generics, from India. This approach allows the company to offer cost-effective products without compromising on quality. The focus on specific formulations, such as probiotics and melatonin, indicates a targeted procurement strategy aimed at fulfilling niche market demands. India's established pharmaceutical manufacturing capabilities and favorable regulatory environment make it a preferred sourcing destination for USPL Nutritionals.

3Market Positioning

Seller's Guide — How to Become a Supplier to M/s. Uspl Nutritionals Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with USPL Nutritionals, especially in the areas of probiotics and melatonin. The company's existing sourcing pattern indicates a preference for high-quality, cost-effective formulations, which Indian manufacturers can provide. Potential gaps in USPL Nutritionals' current sourcing include a limited range of product formulations and a reliance on a small number of suppliers. Indian exporters can capitalize on these gaps by offering diverse product lines and establishing reliable supply chains to meet the company's needs.

2Requirements & Qualifications

Indian exporters aiming to supply USPL Nutritionals must ensure that their products are manufactured in FDA-compliant facilities and possess the necessary GMP certifications recognized by the FDA. Products should undergo batch testing and stability studies to meet U.S. quality standards. Labeling must be in English, providing comprehensive product information. Additionally, exporters should be prepared to navigate the FDA's import licensing requirements and maintain compliance with U.S. regulations governing pharmaceutical imports.

3How to Approach

Frequently Asked Questions — M/s. Uspl Nutritionals Llc

What products does M/s. Uspl Nutritionals Llc import from India?

M/s. Uspl Nutritionals Llc imports 2 pharmaceutical products across 1 categories. Top imports: Probiotics ($249.8K), Melatonin ($150.0K).

Who supplies pharmaceuticals to M/s. Uspl Nutritionals Llc from India?

M/s. Uspl Nutritionals Llc sources from 2 verified Indian suppliers. The primary supplier is Amol Pharmaceuticals Private Limited (74.8% of imports, $702.1K).

What is M/s. Uspl Nutritionals Llc's total pharmaceutical import value?

M/s. Uspl Nutritionals Llc's total pharmaceutical import value from India is $399.8K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M/s. Uspl Nutritionals Llc focus on?

M/s. Uspl Nutritionals Llc imports across 1 categories. The largest: Nutritional Supplements (100.0%).

Get Full M/s. Uspl Nutritionals Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.